Showing results (11-20 of 41) with videos related to
Sort By:
Pageof 5
Leukemia Research|May 3, 2005
Multiple myeloma presenting initially as a solitary pleural effusion later complicated by malignant plasmacytic ascitesYoshio Inoue, Kathrina Chua, Rebecca F McClure, et al.Cancers|June 19, 2024
A Clinical Perspective on Plasma Cell Leukemia: A Single-Center ExperienceAndrew Y Li, Farin Kamangar, Noa G Holtzman, et al.Blood Cancer Journal|December 18, 2023
Addressing the disparities: the approach to the African American patient with multiple myelomaManisha Bhutani, Brandon J Blue, Craig Cole, et al.British Journal of Haematology|July 13, 2010
Tanespimycin with bortezomib: activity in relapsed/refractory patients with multiple myelomaPaul G Richardson, Ashraf Z Badros, Sundar Jagannath, et al.Frontiers in Oncology|July 12, 2021
Prospective Observational Study of Bisphosphonate-Related Osteonecrosis of the Jaw in Multiple Myeloma: Microbiota Profiling and Cytokine ExpressionAshraf Z Badros, Mariam Meddeb, Dianna Weikel, et al.Eye & Contact Lens|December 11, 2020
Corneal Changes After Belantamab Mafodotin in Multiple Myeloma PatientsRebecca B Bausell, Arshia Soleimani, Alfred Vinnett, et al.Haematologica|August 13, 2013
Integrated safety profile of single-agent carfilzomib: experience from 526 patients enrolled in 4 phase II clinical studiesDavid Siegel, Thomas Martin, Ajay Nooka, et al.Integrative Cancer Therapies|May 29, 2014
A pilot study of acupuncture in treating bortezomib-induced peripheral neuropathy in patients with multiple myelomaTing Bao, Olga Goloubeva, Colleen Pelser, et al.Leukemia Research Reports|November 10, 2022
Therapy-related B-lymphoblastic leukemia after multiple myelomaMichael E Kallen, Rima Koka, Zeba N Singh, et al.Research Square|January 7, 2025
Time-restricted eating to address persistent cancer-related fatigue among cancer survivors: A randomized controlled trialAmber S Kleckner, Carin L Clingan, Shari M Youngblood, et al.Pageof 5